Published in Bronchopneumologie on October 20, 1977
Human p300 protein is a coactivator for the transcription factor MyoD. J Biol Chem (1996) 3.05
Submucosal endoscopic tumor resection for subepithelial tumors in the esophagus and cardia. Endoscopy (2012) 2.32
Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res (1997) 2.05
Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription. Mol Cell Biol (2000) 1.71
The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas. Nat Med (1997) 1.69
Regulation of fibronectin EDA exon alternative splicing: possible role of RNA secondary structure for enhancer display. Mol Cell Biol (1999) 1.69
Function of yeast species and strains in wine flavour. Int J Food Microbiol (2003) 1.64
Insulin regulation of lipolysis in nondiabetic and IDDM subjects. Diabetes (1989) 1.55
PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis. Oncogene (1999) 1.49
PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus. EMBO J (1998) 1.47
Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer. Cancer Res (2000) 1.45
Persistent airway inflammation and high exacerbation rate in asthma that starts at menopause. Monaldi Arch Chest Dis (2007) 1.44
Retreatment of non-responder or relapser chronic hepatitis C patients with interferon plus ribavirin vs interferon alone. Ital J Gastroenterol Hepatol (1999) 1.43
Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes. J Biol Chem (1998) 1.38
Critical role played by cyclin D3 in the MyoD-mediated arrest of cell cycle during myoblast differentiation. Mol Cell Biol (1999) 1.35
Increased activation of p38 MAPK in COPD. Eur Respir J (2007) 1.33
Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study. J Clin Oncol (2001) 1.32
Cell cycle control and beyond: emerging roles for the retinoblastoma gene family. Oncogene (2006) 1.29
Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice. Ann Oncol (2007) 1.28
Patient education model for increasing handwashing compliance. Am J Infect Control (1999) 1.27
Host--virus interactions in the control of T4 prereplicative transcription. II. Interaction between tabC (rho) mutants and T4 mot mutants. J Mol Biol (1979) 1.25
Mutations in the retinoblastoma-related gene RB2/p130 in primary nasopharyngeal carcinoma. Cancer Res (2000) 1.22
MyoD induces retinoblastoma gene expression during myogenic differentiation. Oncogene (1994) 1.20
Cellular and molecular effects of protons: apoptosis induction and potential implications for cancer therapy. Apoptosis (2006) 1.18
Pharmacologic effects of intravenously administered aminophylline in asthmatic children. J Pediatr (1970) 1.16
Stem and progenitor cells for liver repopulation: can we standardise the process from bench to bedside? Gut (2008) 1.12
[Total laparoscopic hysterectomy versus vaginal hysterectomy: a prospective randomized trial]. Minerva Ginecol (2007) 1.11
Potential role of potassium channel openers in the treatment of asthma and chronic obstructive pulmonary disease. Life Sci (2002) 1.09
Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non-small lung cancer cells. Cell Prolif (2012) 1.09
Protein kinase C (PKC)-alpha activation inhibits PKC-zeta and mediates the action of PED/PEA-15 on glucose transport in the L6 skeletal muscle cells. Diabetes (2001) 1.09
Adverse drug reactions to antibiotics observed in two pulmonology divisions of catanzaro, Italy: a six-year retrospective study. Pharmacol Res (2002) 1.08
Treatment of severely painful diabetic neuropathy with an aldose reductase inhibitor: relief of pain and improved somatic and autonomic nerve function. Lancet (1983) 1.08
Retrospective analysis of adverse drug reactions to bronchodilators observed in two pulmonary divisions of Catanzaro, Italy. Pharmacol Res (2003) 1.07
Italian real-life experience of omalizumab. Respir Med (2010) 1.06
Slow-channel transgenic mice: a model of postsynaptic organellar degeneration at the neuromuscular junction. J Neurosci (1997) 1.06
Primary head and neck cancer. Histopathologic predictors of recurrence after neck dissection in patients with lymph node involvement. Arch Otolaryngol Head Neck Surg (1994) 1.05
Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease. J Med Genet (2004) 1.04
Long-term results with the titanium bone-anchored hearing aid: the U.S. experience. Am J Otol (1998) 1.04
Interactions of Tn7 and temperate phage F116L of Pseudomonas aeruginosa. Mol Gen Genet (1982) 1.03
Review: Preclinical studies on placenta-derived cells and amniotic membrane: an update. Placenta (2011) 1.02
Targeted gene transfer in eucaryotic cells by dye-assisted laser optoporation. J Photochem Photobiol B (1996) 1.02
Differential expression of Rb2/p130 and p107 in normal human tissues and in primary lung cancer. Clin Cancer Res (1997) 1.01
Inducible pRb2/p130 expression and growth-suppressive mechanisms: evidence of a pRb2/p130, p27Kip1, and cyclin E negative feedback regulatory loop. Cancer Res (2000) 0.99
Differential expression of the retinoblastoma gene family members pRb/p105, p107, and pRb2/p130 in lung cancer. Clin Cancer Res (1996) 0.98
A beta-subunit mutation in the acetylcholine receptor channel gate causes severe slow-channel syndrome. Ann Neurol (1996) 0.98
RB2/p130 gene-enhanced expression down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in vivo. Cancer Res (2001) 0.97
Cytosine methylation transforms an E2F site in the retinoblastoma gene promoter into a binding site for the general repressor methylcytosine-binding protein 2 (MeCP2). Nucleic Acids Res (1999) 0.96
A survey of the enterococci isolated from an artisanal Italian goat's cheese (semicotto caprino). J Appl Microbiol (2000) 0.96
Progenitor cells from the adult mouse brain acquire a neuronal phenotype in response to beta-amyloid. Neurobiol Aging (2005) 0.96
Insulin-activated protein kinase Cbeta bypasses Ras and stimulates mitogen-activated protein kinase activity and cell proliferation in muscle cells. Mol Cell Biol (2000) 0.94
Glia mediates the neuroprotective action of estradiol on beta-amyloid-induced neuronal death. Endocrinology (2004) 0.94
Mouse genes coding for "zinc-finger"-containing proteins: characterization and expression in differentiated cells. Proc Natl Acad Sci U S A (1989) 0.94
[Laparoscopic lymphadenectomy as treatment of endometrial cancer]. Minerva Ginecol (2007) 0.94
Host--virus interactions in the control of T4 prereplicative transcription. I. tabC (rho) mutants. J Mol Biol (1979) 0.93
Liver repopulation with bone marrow derived cells improves the metabolic disorder in the Gunn rat. Gut (2007) 0.92
In NIH-3T3 fibroblasts, insulin receptor interaction with specific protein kinase C isoforms controls receptor intracellular routing. J Biol Chem (1998) 0.92
Experimental analyses of gene-brain-behavior relations: some notes on their application. J Appl Behav Anal (2001) 0.92
CDC2-related kinase PITALRE phosphorylates pRb exclusively on serine and is widely expressed in human tissues. J Cell Physiol (1997) 0.92
Perspectives for genetic engineering of hydrocarbon oxidizing bacteria. Basic Life Sci (1981) 0.91
Soluble leptin receptor and insulin resistance as determinant of sleep apnea. Int J Obes Relat Metab Disord (2002) 0.91
A truncated herpes simplex virus thymidine kinase phosphorylates thymidine and nucleoside analogs and does not cause sterility in transgenic mice. Mol Cell Biol (1995) 0.91
Vasospastic angina and scombroid syndrome: a case report. Acta Clin Belg (2012) 0.90
Association between platelet endothelial cellular adhesion molecule 1 (PECAM-1/CD31) polymorphisms and acute myocardial infarction: a study in patients from Sicily. Eur J Immunogenet (2004) 0.90
Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases. Life Sci (2003) 0.90
Effect of blood gas derangement on QTc dispersion in severe chronic obstructive pulmonary disease: evidence of an electropathy? Int J Cardiol (1997) 0.90
Independent prognostic role of p16 expression in lung cancer. J Thorac Cardiovasc Surg (1999) 0.89
Bystander effect in glioblastoma cells with a predominant cytoplasmic localization of connexin43. Cancer Gene Ther (2008) 0.89
Liposomal-encapsulated doxorubicin plus cyclophosphamide as first-line therapy in metastatic breast cancer: a phase II multicentric study. Ann Oncol (2007) 0.89
Cell cycle related proteins as prognostic parameters in radically resected non-small cell lung cancer. J Clin Pathol (2005) 0.89
Retrospective analysis of adverse drug reactions induced by gemcitabine treatment in patients with non-small cell lung cancer. Pharmacol Res (2004) 0.89
Sites hypersensitive to, and protected from, nuclease digestion in the regulatory region of wild-type and mutant polyoma chromatin. EMBO J (1986) 0.89
Single fiber electromyography of extraocular muscles: a sensitive method for the diagnosis of ocular myasthenia gravis. Muscle Nerve (1995) 0.89
Effects of budesonide on P38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-alpha and Haemophilus influenzae in human bronchial epithelial cells. Int J Immunopathol Pharmacol (2010) 0.89
Prognostic value of p53 in non-small cell lung cancer: relationship with proliferating cell nuclear antigen and cigarette smoking. Hum Pathol (1997) 0.88
Late denervation in patients with antecedent paralytic poliomyelitis. N Engl J Med (1987) 0.88
Biology, prognosis and response to therapy of breast carcinomas according to HER2 score. Ann Oncol (2008) 0.88
Microvascular caliber changes in intramucosal and submucosally invasive esophageal cancer. Endoscopy (2013) 0.87
Sympathetic skin response in diabetic neuropathy. Muscle Nerve (1987) 0.87
Insulin receptor substrate-2 phosphorylation is necessary for protein kinase C zeta activation by insulin in L6hIR cells. J Biol Chem (2001) 0.87
New rat cell line that is highly susceptible to transformation by several oncogenes. Mol Cell Biol (1984) 0.87
Enhanced ganciclovir killing and bystander effect of human tumor cells transduced with a retroviral vector carrying a herpes simplex virus thymidine kinase gene mutant. Hum Gene Ther (2000) 0.87
Role of genetic polymorphisms in myocardial infarction at young age. Clin Hemorheol Microcirc (2010) 0.86
A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease. Pulm Pharmacol (1995) 0.86
p53 immunostaining in differential diagnosis of pleural mesothelial proliferations. Anticancer Res (1997) 0.86
VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment. Gene Ther (2006) 0.85
Mediastinal hibernoma: a case report. J Clin Pathol (2004) 0.85
[Treatment of experimental liver tumors by in vivo suicide gene transfer in rats]. C R Acad Sci III (1992) 0.85
Botulinum neurotoxin type A counteracts neuropathic pain and facilitates functional recovery after peripheral nerve injury in animal models. Neuroscience (2010) 0.84
Treatment of lower respiratory tract infections with ceftriaxone and cefotaxime. A comparative study. Respiration (1986) 0.84
Ambroxol for the prevention of chronic bronchitis exacerbations: long-term multicenter trial. Protective effect of ambroxol against winter semester exacerbations: a double-blind study versus placebo. Respiration (1987) 0.84
Differential role of insulin receptor substrate (IRS)-1 and IRS-2 in L6 skeletal muscle cells expressing the Arg1152 --> Gln insulin receptor. J Biol Chem (1999) 0.84
Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men. Int J Immunogenet (2005) 0.84
Expression of doxorubicin-daunorubicin resistance genes in different anthracycline-producing mutants of Streptomyces peucetius. J Bacteriol (1992) 0.84
Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media. Gene Ther (2007) 0.84
Interleukin-6 receptor superantagonist Sant7 inhibits TGF-beta-induced proliferation of human lung fibroblasts. Cell Prolif (2008) 0.84
Gap junctions in human glioblastomas: implications for suicide gene therapy. Cancer Gene Ther (2011) 0.83
Electrophysiologic studies on locked-in patients: heterogeneity of findings. Electroencephalogr Clin Neurophysiol (1989) 0.83
Variable efficiency of the thymidine kinase/ganciclovir system in human glioblastoma cell lines: implications for gene therapy. Hum Gene Ther (1997) 0.83